Aesthetic devices refer to the devices that are used in cosmetic procedures for beautification, correction and improvement of body contour which includes fillers, breast implants, facial implants and penile implants. Aesthetic injectables refer to gel-such as substances that are injected beneath the skin to restore a more youthful appearance. This includes fillers and Botox. GlobalData uses proprietary data and analytics to provide a comprehensive report on the aesthetic injectables market in the UK. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the aesthetic injectables market in the UK was Allergan Aesthetics followed by Galderma, Merz Pharma GmbH & Co, Sinclair Pharma and Teoxane.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Aesthetic Injectables achieved a benefit by increasing the volume of sunken cheeks or temples, reducing lines around nose and mouth (marionette lines and smile lines), plumping up lips and enhancing facial contour. Aesthetic injectables are grouped into segments based on their molecular composition. Aesthetic injectables include Botulinum Toxin Type A , Hyaluronic Acid (HA) fillers, and Non-Hyaluronic Acid fillers.
The aesthetic injectables market in the UK can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size aesthetic injectables in the UK, buy the report here.